Advanced NanoBiomed Research
Scope & Guideline
Innovating at the Intersection of Science and Medicine
Introduction
Aims and Scopes
- Nanomaterials for Drug Delivery:
Research related to the design and application of nanomaterials as drug delivery systems, enhancing the efficacy and targeting of therapeutic agents. - Tissue Engineering and Regenerative Medicine:
Studies aimed at developing scaffolds and biomaterials for tissue regeneration, focusing on the interaction between cells and engineered materials. - Biosensing and Diagnostics:
Innovations in biosensing technologies utilizing nanomaterials for the detection of biomarkers, pathogens, and diseases. - Cancer Therapy and Immunotherapy:
Research on nanotechnology applications in cancer treatment, including targeted therapy, immunotherapy, and theranostics. - Biocompatible Materials:
Development of biocompatible materials that can interact safely with biological systems for various therapeutic applications. - Microfluidics and Organ-on-a-Chip Technologies:
Application of microfluidic systems for biological assays, drug testing, and modeling of human organs for biomedical research.
Trending and Emerging
- Smart and Responsive Nanocarriers:
Increased research on stimuli-responsive nanocarriers for targeted and controlled drug delivery, which allows for enhanced therapeutic effects and reduced side effects. - Biomimetic Materials:
A growing focus on materials that mimic biological systems, enhancing compatibility and functionality in biomedical applications. - Nanotechnology in Regenerative Medicine:
Emerging studies on the application of nanotechnology for regenerative medicine, including stem cell therapy and tissue repair mechanisms. - Machine Learning and AI in Nanomedicine:
The integration of machine learning and artificial intelligence to predict the behavior of nanomaterials and improve drug design processes is gaining traction. - Multi-Modal Therapeutic Approaches:
Research is increasingly focusing on combination therapies that integrate multiple modalities, including photothermal, photodynamic, and immunotherapy, to enhance cancer treatment outcomes.
Declining or Waning
- Traditional Drug Formulations:
Research focusing on conventional drug formulations and delivery methods seems to be less prevalent, with a shift towards more innovative nanotechnology-based approaches. - Basic Nanomaterial Properties:
Studies that primarily investigate the fundamental properties of nanomaterials without clear biomedical applications are becoming less common. - In Vivo Animal Studies:
There is a noticeable decrease in the number of publications emphasizing in vivo animal studies, as the focus shifts towards more advanced in vitro models and organ-on-a-chip technologies.
Similar Journals
Nanotechnology and Precision Engineering
Shaping the future of engineering with cutting-edge research.Nanotechnology and Precision Engineering is a leading open access journal published by AIP Publishing, dedicated to advancing the fields of nanotechnology and precision engineering. Established in 2006, the journal has become a vital resource for researchers, professionals, and students, reflecting the latest advancements in Electrical and Electronic Engineering, Industrial and Manufacturing Engineering, Instrumentation, Mechanical Engineering, and Nanoscience. With an impressive variety of quartile rankings in Scopus—notably Q1 in several key engineering domains—the journal provides a robust platform for disseminating groundbreaking research. Noteworthy aspects include its open access format introduced in 2018, ensuring that high-quality research is freely accessible to a global audience. By maintaining a commitment to excellence and collaboration, Nanotechnology and Precision Engineering plays a crucial role in shaping the future of technology and innovation.
Advanced Healthcare Materials
Advancing the Frontiers of Biomedical EngineeringAdvanced Healthcare Materials, published by WILEY, is a leading journal in the interdisciplinary fields of biomaterials, biomedical engineering, and pharmaceutical science. With its ISSN 2192-2640 and E-ISSN 2192-2659, the journal provides a platform for innovative research that encompasses the design, fabrication, and application of advanced materials in healthcare settings. Recognized for its high impact, it boasts a Q1 ranking in several categories, including a notable rank of #7/183 in Pharmaceutical Science and 14/137 in Biomaterials according to Scopus rankings. This reflects the journal’s commitment to publishing cutting-edge studies that push the boundaries of science and technology in medicine. Although it operates under a subscription model, articles published in this journal significantly impact the global research community and play a crucial role in the advancement of healthcare technologies. With a publication history from 2012 to 2024, Advanced Healthcare Materials remains an essential resource for researchers, professionals, and students engaged in the groundbreaking intersections of materials science and healthcare.
International Journal of Biomaterials
Unlocking the potential of biomaterials for enhanced medical technologies.The International Journal of Biomaterials, published by HINDAWI LTD, is a premier platform for disseminating groundbreaking research in the fields of biomaterials and biomedical engineering. With an Open Access approach since 2009, this journal provides unhindered access to innovative studies and applications aimed at advancing medical technologies and improving patient outcomes. Notably ranked in the Q3 category for both Biomaterials and Biomedical Engineering in 2023, it serves as an essential resource for researchers, practitioners, and students alike. The journal's Scopus rankings, including a 49th percentile in Biomedical Engineering and a 40th percentile in Biomaterials, further underscore its growing prominence in the academic community. With contributions spanning from 2011 to 2024, the journal seeks to foster collaborative research and promote developments that enhance the understanding and application of biomaterials in healthcare.
VIEW
Shaping Tomorrow's Solutions in Biomedical Engineering.VIEW is a prestigious journal published by WILEY that focuses on the rapidly evolving fields of Biomaterials and Biomedical Engineering. Since its inception in 2020, VIEW has established itself as an open-access platform dedicated to disseminating high-quality research and innovation within these disciplines. With an impressive impact factor that places it in the Q1 category of both Biomaterials and Biomedical Engineering, VIEW ranks among the top journals in its field, boasting a 91st percentile ranking in Biomedical Engineering and an 85th percentile ranking in Materials Science. Researchers, professionals, and students are encouraged to utilize this invaluable resource, as it provides a comprehensive view of current advancements and future trends in biomaterial science and engineering. Positioned in the United Kingdom, VIEW operates as a vital scholarly communication link, fostering collaboration and knowledge sharing within an ever-growing global community.
COLLOIDS AND SURFACES B-BIOINTERFACES
Advancing Knowledge at the Intersection of Biology and ChemistryCOLLOIDS AND SURFACES B-BIOINTERFACES is a premier interdisciplinary journal published by Elsevier, dedicated to advancing the knowledge of interfaces and interactions in biological systems and their applications in biotechnology. With an impressive impact factor that underscores its significance in the field, the journal ranks in the Q1 category for Biotechnology, Medicine, and Physical and Theoretical Chemistry in the 2023 classifications. It has achieved notable positions in Scopus rankings, highlighted by a top-tier rank in Colloid and Surface Chemistry, demonstrating its influence on ongoing research. Spanning from 1993 to 2025, C&B B-BIOINTERFACES serves as a vital platform for innovative research contributions, fostering knowledge exchange among researchers, professionals, and students. The journal focuses on the intricate relationships between colloids, surfaces, and biological materials, paving the way for groundbreaking developments in drug delivery, biomaterials, and nanotechnology. While not an open-access publication, readers can anticipate insightful, high-quality articles that significantly impact the scientific community.
IET Nanobiotechnology
Innovating at the Intersection of Nanotech and Biology.IET Nanobiotechnology, published by WILEY-HINDAWI in the United Kingdom, is a leading journal dedicated to advancing the field of nanobiotechnology by exploring the interplay between nanotechnology and biological systems. With an impressive impact factor and a significant coverage in Scopus rankings, this journal occupies a pivotal position within the Q2 and Q3 quartiles across various relevant disciplines, including Biotechnology, Electrical and Electronic Engineering, and Nanoscience. Since its inception in 2007, the journal has showcased a diverse range of high-quality research that facilitates the development of innovative nanomaterials and their applications in medicine, biosensing, and bioengineering. Open access to its articles ensures that cutting-edge advancements are readily accessible to the global research community, fostering collaboration and knowledge sharing. As the field of nanobiotechnology continues to evolve, IET Nanobiotechnology remains a crucial resource for researchers, professionals, and students striving to shape the future of this interdisciplinary domain.
BIOMEDICAL MICRODEVICES
Unleashing Potential in Biomedical MicrodevicesBIOMEDICAL MICRODEVICES is a leading journal published by Springer that focuses on the innovative field of microdevices within biomedical engineering. With an ISSN of 1387-2176 and an E-ISSN of 1572-8781, BIOMEDICAL MICRODEVICES offers a prestigious platform for researchers to disseminate their findings from 1998 to 2024, demonstrating a long-standing commitment to advancing knowledge in this critical area. The journal is recognized for its significant contributions, boasting a Q2 ranking in Biomedical Engineering and Nanoscience and Nanotechnology, and a Q3 rank in Molecular Biology. Renowned for its rigorous peer-review process, it is positioned within the top 30% of its field according to Scopus rankings, making it a valuable resource for researchers and practitioners alike. Though it operates under a subscription model, the emphasis on quality and relevance within its scope ensures that BIOMEDICAL MICRODEVICES remains a vital source of cutting-edge research that bridges engineering and biological systems, fostering innovation and collaboration in the pursuit of novel health solutions.
Regenerative Biomaterials
Empowering Collaboration in Biomaterials ResearchRegenerative Biomaterials, published by Oxford University Press, serves as a premier platform for the dissemination of innovative research in the rapidly evolving field of biomaterials. Since its inception in 2014, this esteemed open-access journal has fostered a collaborative and diverse scientific community, providing free access to impactful articles that enhance our understanding of regenerative medicine and tissue engineering. With a commendable impact factor and ranking within the top quartiles of both Biomedical Engineering and Materials Science, it is recognized for its rigorous peer-review process and high-quality publications. The journal aims to bridge the gap between fundamental research and applied sciences, promoting advanced studies that contribute to clinical applications and regeneration strategies. Researchers, practitioners, and students alike are encouraged to engage with the journal’s content to foster interdisciplinary collaboration and drive future innovations in the biomaterials domain.
Acta Biomaterialia
Exploring the Future of Biochemical and Biomedical SolutionsActa Biomaterialia, published by Elsevier Science Ltd, is a leading journal in the fields of biochemistry, biomaterials, biomedical engineering, biotechnology, and molecular biology. With an ISSN of 1742-7061 and an E-ISSN of 1878-7568, this prestigious journal has secured a remarkable position in the academic community, evidenced by its inclusion in the Q1 category across multiple disciplines for 2023. It ranks impressively at #21 in biochemistry, #16 in biomedical engineering, #18 in biotechnology, and #11 in biomaterials, reflecting its high impact and relevance to ongoing research and development. The journal provides a platform for disseminating innovative research and advancements in the design and application of biomaterials, contributing to scientific discussions that propel the field forward. Although it does not currently offer open access options, Acta Biomaterialia continues to attract contributions that advance our understanding of biomaterials and their interactions with biological systems, ensuring that researchers, professionals, and students remain informed about the latest trends and breakthroughs in this rapidly evolving area of study.
ACS Applied Bio Materials
Innovating the Future of Bioengineering and Materials ScienceACS Applied Bio Materials is a leading academic journal published by the American Chemical Society, focusing on the innovative intersection of bioengineering and materials science. Since its inception in 2018, the journal has established itself as a pivotal platform for disseminating impactful research within the fields of Biochemistry, Biomaterials, Biomedical Engineering, and Chemistry, often ranked in the top tiers of these categories. With an impressive impact factor, it holds a Q2 ranking in both Biochemistry and Biomaterials, and a prestigious Q1 ranking in Biomedical Engineering and miscellaneous Chemistry, underscoring its significance in advancing knowledge and practices across these disciplines. The journal’s editorial commitment to high-quality, peer-reviewed research ensures relevance and rigor, appealing to a diverse audience of researchers, professionals, and students keen to explore breakthroughs in bio-related materials technology. The access options enhance its visibility and reach, allowing for a broader dissemination of studies that drive innovation and collaboration in biotechnology and material sciences. Located in the heart of Washington, DC, ACS Applied Bio Materials serves as a crucial resource for advancing the future of healthcare, engineering, and materials research.